Patent: 8,663,711
✉ Email this page to a colleague
Summary for Patent: 8,663,711
Title: | Use of armillaridin for treating cancer |
Abstract: | Novel Uses of an aromatic ester isolated from Armillaria mellea, particularly, armillaridin, are disclosed herein. The armillaridin is useful for manufacturing a medicament or a pharmaceutical composition for suppressing the growth of cancerous cells or for enhancing susceptibility of esophageal cancerous cells to a radiation treatment, in a subject. |
Inventor(s): | Chen; Yu-Jen (Taipei, TW), Chen; Chien-Chih (Taipei, TW) |
Assignee: | Mackay Memorial Hospital (New Taipei, TW) |
Application Number: | 13/342,642 |
Patent Claims: | see list of patent claims |
Details for Patent 8,663,711
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2039-02-26 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2039-02-26 |
Amgen, Inc. | VECTIBIX | panitumumab | Injection | 125147 | 09/27/2006 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |